The U.S. Food and Drug Administration (FDA) staff returning to the office face mounting concerns over inadequate workspaces and parking limitations. As of Monday, around 18,000 employees are expected back, following directives to end remote work. Warnings about these disruptions were issued in various FDA division meetings.
About the Author
